Teladoc Health, Inc. (NYSE:TDOC) Director Buys $52,990.00 in Stock

Teladoc Health, Inc. (NYSE:TDOC) Director Thomas Mckinley bought 7,000 shares of Teladoc Health stock in a transaction on Tuesday, August 6th. The stock was acquired at an average price of $7.57 per share, with a total value of $52,990.00. Following the completion of the purchase, the director now directly owns 31,077 shares of the company’s stock, valued at $235,252.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Teladoc Health Stock Performance

Shares of TDOC stock traded up $0.05 during mid-day trading on Thursday, reaching $7.22. The stock had a trading volume of 6,450,411 shares, compared to its average volume of 5,519,156. Teladoc Health, Inc. has a one year low of $7.14 and a one year high of $25.84. The firm has a market cap of $1.22 billion, a PE ratio of -5.12 and a beta of 0.93. The firm’s 50 day simple moving average is $9.65 and its 200 day simple moving average is $13.39. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of TDOC. Federated Hermes Inc. raised its stake in shares of Teladoc Health by 6.6% in the 2nd quarter. Federated Hermes Inc. now owns 121,654 shares of the health services provider’s stock valued at $1,190,000 after buying an additional 7,549 shares in the last quarter. American Century Companies Inc. increased its stake in Teladoc Health by 31.0% in the second quarter. American Century Companies Inc. now owns 136,351 shares of the health services provider’s stock valued at $1,334,000 after acquiring an additional 32,240 shares during the period. Headlands Technologies LLC acquired a new position in Teladoc Health in the second quarter worth about $198,000. Doheny Asset Management CA bought a new position in Teladoc Health during the second quarter worth about $46,000. Finally, Monaco Asset Management SAM acquired a new stake in Teladoc Health during the second quarter valued at approximately $1,222,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on TDOC shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, August 1st. DA Davidson reduced their price target on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a research report on Thursday, August 1st. Stifel Nicolaus decreased their price target on Teladoc Health from $16.00 to $9.00 and set a “hold” rating for the company in a research note on Thursday, August 1st. Truist Financial cut their price objective on Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research note on Friday, August 2nd. Finally, Oppenheimer decreased their target price on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a research report on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $13.56.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.